Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.
Press releases published on July 9, 2025
Updated Edition of Good Awkward Adds National Study on Communication and Workplace Performance
EIN Presswire
·
July 9, 2025
The updated paperback of Good Awkward includes new national research on how workplace awkwardness impacts trust, influence, and team success. PHILADELPHIA, PA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Good Awkward, the award-winning workplace …
Kaskela Law LLC Announces Investigation of UnitedHealth Group Inc. (NYSE: UNH) on Behalf of Long-Term UNH Shareholders
EIN Presswire
·
July 9, 2025
UnitedHealth Group (NYSE:UNH) PHILADELPHIA, PA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Kaskela Law LLC announces that it is investigating UnitedHealth Group Inc. (NYSE: UNH) (“UnitedHealth”) on behalf of the company’s long-term investors. …
Federal Hearings and Appeals Services (FHAS) Receives Georgia Certification as Independent Review Organization
EIN Presswire
·
July 9, 2025
Third state certification in 2025 expands FHAS’s IRO reach to over 29 states …
Gozellix Receives Permanent HCPCS Code
GlobeNewswire
·
July 9, 2025
MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA1 PET2 imaging agent, Gozellix® (kit for the preparation of gallium-68 ( …
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
July 9, 2025
BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
GlobeNewswire
·
July 9, 2025
RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, …
Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
GlobeNewswire
·
July 9, 2025
Jason Campagna, MD, PhD, joins Inventiva as President of R…
Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité
GlobeNewswire
·
July 9, 2025
Jason Campagna, MD, PhD, rejoint Inventiva en tant que Président de la R…
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 9, 2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
GlobeNewswire
·
July 9, 2025
The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These results …
Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
July 9, 2025
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM) Secured $15M license …
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
GlobeNewswire
·
July 9, 2025
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation
GlobeNewswire
·
July 9, 2025
OXFORD, United Kingdom and MADISON, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert Award by the Royal Academy of Engineering. The award, …
Advanced Materials Market in Focus: BCC Research Publishes 2024 Sector Review
GlobeNewswire
·
July 9, 2025
Boston, July 09, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its " 2024 Advanced Materials Research Review," offering a deep dive into one of today’s most dynamic and fast-growing markets. This comprehensive report explores the latest …
HOOPP announces changes to its Executive Leadership Team
GlobeNewswire
·
July 9, 2025
TORONTO, July 09, 2025 (GLOBE NEWSWIRE) -- Today, the Healthcare of Ontario Pension Plan (HOOPP) is pleased to announce changes to its executive leadership team. Linda Halley has been promoted to Chief Risk Officer. Linda has been with HOOPP for 24 years …
Press release: Transparency Notification from Shareholders
GlobeNewswire
·
July 9, 2025
Transparency Notification from Shareholders Ghent, Belgium – 9 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and …
Investment into Saskatchewan pea protein processing to create new Canadian food options
GlobeNewswire
·
July 9, 2025
Yorkton, SK, July 09, 2025 (GLOBE NEWSWIRE) -- The growth of the plant-protein sector has led to rising demand for Canadian-made protein alternatives that meet the flavour and nutrition profiles of their traditional counterparts. Today, Protein Industries …
KRAS Inhibitors Market Size Clinical Trials Patent Approved Drugs Sales Insight
GlobeNewswire
·
July 9, 2025
Delhi, July 09, 2025 (GLOBE NEWSWIRE) -- Global KRAS Inhibitors Market, Drug Sales, Patent, Price and Clinical Trials Insight 2030 Report Findings …
US Orphan Drug Market Size Trends FDA Designation By Indication Orphan Drug Sales Clinical Research Insight
GlobeNewswire
·
July 9, 2025
Delhi, July 09, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030 …
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
GlobeNewswire
·
July 9, 2025
RIYADH, Saudi Arabia, July 09, 2025 (GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital …